Who we are
ABOUT MEDICINES FOR EUROPE
PURPOSE AND OBJECTIVES
OUR VALUES – OUR 5 PILLARS
STRUCTURE
MEMBERS
BECOME A MEMBER
CODE OF CONDUCT
DISCLOSURE
Key topics
COVID-19
ACCESS
INDUSTRIAL POLICY
REGULATORY AND LEGAL FRAMEWORK
FALSIFIED MEDICINES
ENVIRONMENT
ANTIMICROBIAL RESISTANCE
MEDICINE SHORTAGES
Publications
EXTERNAL RESOURCES
FACTSHEETS
INFOGRAPHICS
PODCAST
POLICY
REPORTS
VIDEOS
Newsroom
IN THE NEWS
PRESS RELEASES
Contact us
Login
Generic medicines
Home
Medicines for Europe
Generic medicines Group
MISSION AND VISION
STRUCTURE
MEMBERS
BECOME A MEMBER
Did you know?
Definition
THERAPEUTIC AREAS
GLOSSARY
Q&A
What’s new
FACTSHEETS
POLICY
REPORTS
VIDEOS
INFOGRAPHICS
Our 5 pillars
Patients
QUALITY
VALUE
SUSTAINABILITY
PARTNERSHIP
Find out more
Related links
Contact us
Twitter
Biosimilar medicines
Home
Medicines for Europe
Biosimilar medicines Group
MISSION AND VISION
STRUCTURE
MEMBERS
BECOME A MEMBER
Did you know?
DEFINITION
THERAPEUTIC AREAS
GLOSSARY
Q&A
What’s new
FACTSHEETS
POLICY
REPORTS
VIDEOS
INFOGRAPHICS
External resources
Our 5 pillars
Patients
QUALITY
VALUE
SUSTAINABILITY
PARTNERSHIP
Find out more
Related links
Contact us
Twitter
Value added medicines
Home
Who we are
Value added medicines Group
MISSION AND VISION
STRUCTURE
MEMBERS
BECOME A MEMBER
Did you know?
Definition
THERAPEUTIC AREAS
Q&A
What’s new
FACTSHEETS
POLICY
REPORTS
VIDEOS
INFOGRAPHICS
Our 5 pillars
Patients
QUALITY
VALUE
SUSTAINABILITY
PARTNERSHIP
Find out more
Contact us
Events
Newsroom
News about
By type
In the news
Press releases
Twitter
Tweets
Videos
Photos
EU must bolster Biosimilar medicines policy to increase equity of access and bring much needed savings to healthcare budgets
25 May 2023
Read More
LETTER: Medicines Security of Supply
9 May 2023
Read More
Bulgarian National Television – The EU is preparing the most extensive changes in medical legislation in 20 years
4 May 2023
Open
Read more
Euronews – New EU medicine rules, articifical intelligence and fast fashion
4 May 2023
Adrian Van Der Hoven joins panelists elaborating on the EU […]
Read more
Across Europe – on average – 26% of all generic medicines have disappeared
4 May 2023
Read More
Future of pharmaceutical policy rests on secure supply of essential medicines
3 May 2023
Read More
Patients should benefit from greater access under new patent package proposals
27 April 2023
Read More
Reaction to EU Pharmaceutical legislation: Timely and equitable access for patients and security of supply essential for reform
26 April 2023
Read More
Harmonised bioequivalence guideline paves the way for global generic medicine development and access to medicines
26 April 2023
Read More
Pharmaphorum – Why ‘reduce, reuse, and recycle’ medicine is the future
19 April 2023
Open
Read more
Posts navigation
1
2
3
…
33
Subscribe to our newsletter
Medicines For Europe
Who we are
Key topics
Publications
Newsroom
Contact us
SECTOR GROUPS
Generic medicines
WHO WE ARE
DID YOU KNOW?
WHAT’S NEW
OUR 5 PILLARS
FIND OUT MORE
Biosimilar medicines
WHO WE ARE
DID YOU KNOW?
WHAT’S NEW
OUR 5 PILLARS
FIND OUT MORE
Value added medicines
WHO WE ARE
DID YOU KNOW?
WHAT’S NEW
OUR 5 PILLARS
Events
Tweet
Tweet
Tweet
LinkedIn